1.Nicholson, HD, Hardy, MP. Luteinizing hormone differentially regulates the secretion of testicular oxytocin and testosterone by purified adult rat Leydig cells in vitro. Endocrinology 1992; 130:671–677.
2.Carreau, S, Bilinska, B, Levallet, J. Male germ cells. A new source of estrogens in mammalian testis. Ann. Endocrinol. 1998; 59:79–92.
3.Waeber, C, Reymond, O, Reymond, M, Lemarchand-Beraud, T. Effects of hyper- and hypoprolactinemia on gonadotropin secretion, rat testicular luteinizing hormone/human chorionic gonadotropin receptors and testosterone production by isolated Leydig cells. Biol. Reprod. 1983; 28:167–177.
4.Neaves, WB, Johnson, L, Petty, CS. Age-related change in numbers of other interstitial cells in testes of adult men: evidence bearing on the fate of Leydig cells lost with advanced age. Biol. Reprod. 1985; 33:259–269.
5.Gray, A, Berlin, JA, McKinley, JB, Longcope, C. An examination of research design effects on the association of testosterone and male ageing: results of a meta analysis. J. Clin. Epidemiol. 1991; 44:671–684.
6.Cheng, CY, Mruk, DD. The blood-testis barrier and its implications for male contraception. Pharmacol. Rev. 2012; 64:16–64.
7.Ragheb, AM, Sabanegh, Jr ES. Smoking and male fertility: a contemporary review. Arch. Med. Sci. 2009; 5:S13–S19.
8.Lee, NPY, Cheng, CY. Nitric oxide/nitric oxide synthase, spermatogenesis, and tight junction dynamics. Biol. Reprod. 2004; 70:267–276.
9.Johnson, L, Zane, RS, Petty, CS, Neaves, WB. Quantification of the human Sertoli cell population: Its distribution, relation to germ cell numbers, and age related decline. Biol. Reprod. 1984; 31:785–795.
10.Girsh, E, Katz, N, Genkin, L, et al. Male age influences oocyte-donor program results. J. Assist. Reprod. Genet. 2008; 25:137–143.
11.Masliukaite, I, Hagen, JM, Jahnukainen, K, et al. Establishing reference values for age related spermatogonial quantity in prepubertal human testes: a systematic review and meta-analysis. Fertil. Steril. 2016; 106:1652–1657.
12.Paniagua, R, Nistal, M. Morphological and histometric study of human spermatogonia from birth to the onset of puberty. J. Anat. 1984; 139:535–552.
13.Trainer, TD. Histology of the normal testis. Am. J. Surg. Pathol. 1987; 11:787–809.
14.Sharpe, RM, McKinnell, C, Kivlin, C, Fisher, JS. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 2003; 125:769–784.
15.Hecht, NB. Molecular mechanisms of male germ cell differentiation. Bioassays 1998; 20:555–561.
16.Hecht, NB. The making of a spermatozoon: a molecular perspective. Dev. Genet. 1995; 16:95–103.
17.Gill-Sharma, MK, Choudhuri, JD, Souza, S. Sperm chromatin protamination: an endocrine perspective. Protein Pept. Lett. 2011; 18:786–801.
18.Carrell, DT, Emery, BR, Hammoud, S. Altered protamine expression and diminished spermatogenesis: what is the link? Hum. Reprod. Update 2007; 13:313–327.
19.Jager, S. Sperm nuclear stability and male infertility. Arch. Androl. 1990; 25:253–259.
20.Oliva, R. Protamines and male infertility. Hum. Reprod. Update 2006; 12:417–435.
21.Carrell, DT, Emery, BR, Hammoud, S. The aetiology of sperm protamine abnormalities and their potential impact on the sperm epigenome. Int. J. Androl. 2008; 31:537–545.
22.Brumlow, WB, Adams, CS. Immunocytochemical detection of prolactin or prolactin-like immunoreactivity in epididymis of mature male mouse. Histochemistry 1990; 93:299–304.
23.Dacheux, JL, Dacheux, F. New insights into epididymal function in relation to sperm maturation. Reproduction 2014; 147:R27–R42.
24.Turner, RM. Moving to the beat: a review of mammalian sperm motility regulation. Reprod. Fert. Dev. 2006; 18:25–38.
25.Lotti, F, Corona, G, Maseroli, E, et al. Clinical implications of measuring prolactin levels in males of infertile couples. Andrology 2013; 1:764–771.
26.Rastrelli, G, Corona, G, Maggi, M. The role of prolactin in andrology: what is new? Rev. Endocr. Metab. Disord. 2015; 16:233–248.
27.Zukerman, Z, Weiss, DB, Orvieto, R. Does preejaculatory penile secretion originating from Cowper’s gland contain sperm? J. Assist. Reprod. Gen. 2003; 20:157–159.
28.Björndahl, L, Kvist, U. Sequence of ejaculation affects the spermatozoon as a carrier and its message. RBM Online 2003; 7:440–448.
29.Lilja, H, Lundwall, A. Molecular cloning of epididymal and seminal vesicular transcripts encoding a semenogelin-related protein. Proc. Natl. Acad. Sci. U. S. A. 1992; 89:4559–4563.
30.Zaneveld, LG, Tauber, PF. Contribution of prostatic fluid components to the ejaculate. Prog. Clin. Biol. Res. 1981; 75A:265–277.
31.Tomar, AK, Sooch, BS, Singh, S, Yadav, S. Differential proteomics of human seminal plasma: a potential target for searching male infertility marker proteins. Proteomics Clin. Appl. 2012; 6:147–151.
32.Peter, A, Lilja, H, Lundwall, A, Malm, J. Semenogelin I and semenogelin II, the major gel-forming proteins in human semen, are substrates for transglutaminase. Eur. J. Biochem. 1998; 252:216–221.
33.Suzuki, K, Kise, H, Nishioka, J, Hayashi, T. The interaction among protein C inhibitor, prostate-specific antigen, and the semenogelin system. Semin. Thromb. Hemost. 2007; 33:46–52.
34.Sobrero, AJ, Macleod, J. The immediate postcoital test. Fertil. Steril. 1962; 13:184–189.
35.Perloff, WH, Steinberger, E. In-vitro penetration of cervical mucus by spermatozoa. Fertil. Steril. 1963; 14:231–236.
36.Publicover, S, Harper, CV, Barratt, C. [Ca2+]i signaling in sperm—making the most of what you’ve got. Nat. Cell Biol. 2007; 9:235–242.
37.Rode, B, Dirami, T, Bakouh, N, et al. The testis anion transporter TAT1 (SLC26A8) physically and functionally interacts with the cystic fibrosis transmembrane conductance regulator channel: a potential role during sperm capacitation. Hum. Mol. Genet. 2012; 21:1287–1298.
38.Krausz, C, Bonaccorsi, L, Luconi, M, et al. Intracellular calcium increase and acrosome reaction in response to progesterone in human spermatozoa are correlated with in-vitro fertilization. Hum. Reprod. 1995; 10:120–124.
39.Ankri, R, Friedman, H, Savion, N, et al. Visible light induces nitric oxide (NO) formation in sperm and endothelial cells. Lasers Surg. Med. 2010; 42:348–352.
40.Suarez, SS. Control of hyperactivation in sperm. Hum. Reprod. Update 2008; 14:647–657.
41.Nomikos, M, Kashir, J, Swann, K, Lai, FA. Sperm PLCζ: from structure to Ca2+ oscillations, egg activation and therapeutic potential. FEBS Lett. 2013; 587:3609–3616.
42.Escoffier, J, Yassine, S, Lee, HC, et al. Subcellular localization of phospholipase Cζ in human sperm and its absence in DPY19L2-deficient sperm are consistent with its role in oocyte activation. Mol. Hum. Reprod. 2015; 21:157–168.
43.Heytens, E, Parrington, J, Coward, K, et al. Reduced amounts and abnormal forms of phospholipase C zeta (PLCzeta) in spermatozoa from infertile men. Hum. Reprod. 2009; 24:2417–2428.
44.Kashir, J, Konstantinidis, M, Jones, C, et al. A maternally inherited autosomal point mutation in human phospholipase C zeta (PLCzeta) leads to male infertility. Hum. Reprod. 2012; 27:222–231.
45.Küĉükkömürcü, S, Delogne-Desnoeck, J, Robyn, C. Prolactin and fructose in human seminal fluid. Int. J. Fertil. 1980; 25:117–121.
46.Meikle, AW, Stephenson, RA, Lewis, CM, Wiebke, GA, Middleton, RG. Age, genetic, and nongenetic factors influencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins. Prostate 1997; 33:105–111.
47.Chianese, R, Cobellis, G, Chioccarelli, T, et al. Kisspeptins, estrogens and male fertility. Curr. Med. Chem. 2016; 23:4070–4091.
48.Eskenazi, B, Wyrobek, AJ, Sloter, E, et al. The association of age and semen quality in healthy men. Hum. Reprod. 2003; 18:447–454.
49.Slama, R, Bouyer, J, Windham, G, et al. Influence of paternal age on the risk of spontaneous abortion. Am. J. Epidemiol. 2005; 161:816–823.
50.Sartorius, GA, Nieschlag, E. Paternal age and reproduction. Hum. Reprod. Update 2010; 16:65–79.
51.Singh, NP, Muller, CH, Berger, RE. Effects of age on DNA double-strand breaks and apoptosis in human sperm. Fertil. Steril. 2003; 80:1420–1430.
52.Robinson, L, Gallos, ID, Conner, SJ, et al. The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis. Hum. Reprod. 2012; 27:2908–2917.
53.Ford, WCL, North, K, Taylor, H, et al. Increasing paternal age is associated with delayed conception in a large population of fertile couples: evidence for declining fecundity in older men. The ALSPAC Study Team (Avon Longitudinal Study of Pregnancy and Childhood). Hum. Reprod. 2000; 15:1703–1708.
54.Hassan, MA, Killick, SR. Effect of male age on fertility: evidence for the decline in male fertility with increasing age. Fertil. Steril. 2003; 79:1520–1527.
55.Yang, Q, Wen, SW, Leader, A, et al. Paternal age and birth defects: how strong is the association? Hum. Reprod. 2007; 22:696–701.
56.Orioli, IM, Castilla, EE, Scarano, G, Mastroiacovo, P. Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfecta. Am. J. Med. Genet. 1995; 59:209–217.
57.Lauritsen, MB, Pedersen, CB, Mortensen, PB. Effects of familial risk factors and place of birth on the risk of autism: a nationwide register-based study. J. Child. Psychol. Psychiatry 2005; 46:963–971.
58.Lawson, G, Fletcher, R. Delayed fatherhood. J. Fam. Plann. Reprod. Health Care 2014; 40:283–288.
59.Gray, A, Berlin, JA, McKinlay, JB, Longcope, C. An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J. Clin. Epidemiol. 1991; 44:671–684.
60.Nieschlag, E. The endocrine function of the human testis in regard to sexuality. Ciba Found. Symp. 1978; 14:183–208.
61.Diver, MJ, Imtiaz, KE, Ahmad, AM, Vora, JP, Fraser, WD. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin. Endocrinol. (Oxf.) 2003; 58:710–717.
62.Davidson, JM, Chen, JJ, Crapo, L, et al. Hormonal changes and sexual function in aging men. J. Clin. Endocrinol. Metab. 1983; 57:71–77.
63.Johnson, JM, Nachtigall, LB, Stern, TA. The effect of testosterone levels on mood in men: a review. Psychosomatics 2013; 54:509–514.
64.Hawton, KE. Sexual problems associated with physical illness. In: Weatherall, DJ, Ledingham, JG, Warrell, DA, eds., Oxford Textbook of Medicine. Oxford: Oxford University Press. 1997; 4243–4247.
65.Lašaitė, L, Čeponis, J, Preikša, RT, Žilaitienė, B. Effects of two-year testosterone replacement therapy on cognition, emotions and quality of life in young and middle-aged hypogonadal men. Andrologia 2017; 49(3):10.1111/and.12633.
66.Janowsky, JS, Oviatt, SK, Orwoll, ES. Testosterone influences spatial cognition in older men. Behav. Neurosci. 1994; 108:325–332.
67.Finkelstein, JS. Androgens and bone metabolism. In: Nieschlag, E, Behre, HM, eds., Testosterone: Action, Deficiency, Substitution. Berlin: Springer Verlag. 1998; 187–207.
68.Bhasin, S, Storer, TW, Berman, N, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J. Clin. Endocrinol. Metab. 1997; 82:407–413.
69.Haider, A, Yassin, A, Haider, KS, et al. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study. Vasc. Health Risk Manag. 2016; 14:251–261.